-- 据杰富瑞（Jefferies）周五发布的报告显示，REA集团（ASX：REA）住宅购买收益率的增长在市场环境依然低迷的情况下成为其第三财季业绩的主要驱动力。 REA在澳大利亚的住宅收入增长了12%，几乎完全得益于收益率的提升，因为全国范围内的房源挂牌量仅增长了1%。购买收益率增长了14%。 由于价格上涨和项目开工量增加，商业地产和新房业务实现了两位数的增长。 自由现金流为1.35亿澳元，基本持平，这可能表明该季度存在一些“波动性”的资本支出。 杰富瑞维持对REA的“买入”评级，目标价为每股192澳元。
Related Articles
Asia
Regis Resources Says Morgan Stanley, Units Acquire 5.87% Stake
Regis Resources (ASX:RRL) said Morgan Stanley and its subsidiaries became a substantial holder of the firm after acquiring 44.4 million shares, or a 5.87% stake, on Tuesday, according to a Friday Australian bourse filing.
$ASX:RRL
Asia
Jumpcan Pharma's Jianwei Xiaoshi Oral Liquid Added to China's Centralized Procurement Program
Hubei Jumpcan Pharmaceutical's (SHA:600566) Jianwei Xiaoshi Oral Liquid was selected for the National Chinese Patent Medicine's centralized procurement, according to a Friday disclosure to the Shanghai bourse.The drug is used to treat food stagnation and indigestion.During the procurement period, medical institutions will prioritize the use of the selected products, the pharmaceutical company said.
$SHA:600566
Asia
Tabcorp Likely Faces Remediation Costs from Austrac Probe, But Sell-Off Overdone, Jarden Says
Tabcorp Holdings (ASX:TAH) likely faces remediation costs in a new regulatory enforcement investigation, and repeat offender status is also a risk, but neither of those factors justifies the magnitude of the sell-off in the company's stock, Jarden said in a Thursday note.The Australian Transaction Reports and Analysis Center (AUSTRAC) is investigating the company's compliance with anti-money laundering and counter-terrorism financing obligations, citing concerns about its ability to identify and mitigate risks.Jarden noted there is no certainty of a financial penalty as the regulator's disclosure stated that all outcomes are on the table, while previous cases show that a zero-penalty result is possible when the regulator is satisfied with cooperation.AUSTRAC's previous gambling sector penalties have ranged from zero to AU$450 million, the equity research firm said, adding that it views top-line implications for Tabcorp as limited.The company's shares fell sharply after the disclosure of the probe, and at those levels, "the stock appears to be factoring a cost impost well in excess of what the precedent set supports," Jarden said.It maintained an overweight rating on Tabcorp with a target price of AU$1.05, saying it will revisit those assessments if Austrac files civil penalty proceedings or Tabcorp takes on provisions related to the case.The company's shares fell 13% in recent Friday trade.
$ASX:TAH